EFFICACY AND SAFETY OF IV IRON SUCROSE IN CHILDREN TREATED FOR IRON DEFICIENCY ANEMIA
Main Article Content
Keywords
Iron deficiency anemia, Intravenous sucrose, Children, Efficacy
Abstract
Background and Aim: Mostly cases of iron deficiency anemia caused by childhood malnutrition managed with oral iron supplements. However, intravenous (IV) iron is an option for those with severe Iron deficiency anemia who struggle with oral absorption of iron supplementation. Therefore, the present study aimed to investigate the efficacy and safety of intravenous (IV) iron sucrose in children treated for iron deficiency anemia.
Patients and Methods: Experimental research was conducted by giving intravenous iron sucrose to the patents between age of 3 months to 12 years, presented with iron deficiency anemia, within a control setting of Paediatrics intensive care unit CMH Peshawar. Routine blood screening including Hb, serum ferritin, MCV, MCHC, HCT, etc count and RBC count were done and results were recorded prior to IV iron therapy. IV iron sucrose was given with maximum dose of 7mg/kg every 3 to 7 days (not exceeding than 300mg/dose) until total dose is given. The patients were followed and relevant laboratory tests were repeated after one month of last dose of IV iron therapy. Demographics, baseline characteristics, and laboratory parameters such as hemoglobin levels, ferritin levels, and other associated variables were recorded for each patient. SPSS version 26 was used for descriptive statistics.
Results: The overall mean age was 5.36 ± 4.56 years (age range 0-15 years). The Nutritional iron deprivation was the most prevalent cause of iron deficiency anemia. The mean value of hemoglobin (g/dL) at baseline and after 30 days was 7.21 ± 0.74 and 11.86 ± 0.76, respectively. There were 41 (53.9%) male and 35 (45.1%) female. Prior to IV treatment, the mean corpuscular volume (MCV) was 64.83 ± 4.49 fL, which increased to 89.16 ± 7.69 fL after 30 days treatment. Similarly, there was significant difference observed in ferritin levels before (6.89 ± 4.45 μg/L) and after (48.59 ± 4.79 μg/L) the treatment.
Conclusion: Administration of IV sucrose for the treatment of iron deficiency anemia is effective, safe, and can significantly improve iron and hemoglobin levels.
References
2. Butragueño‐Laiseca L, de la Mata Navazo S, Sánchez Galindo AC, Santiago Lozano MJ. Intravenous iron for critically ill children. Comparison of three dose regimens. Pediatric blood & cancer. 2024 Jan;71(1):e30734.
3. Malik NA, Shah SA, Mashhadi SF. Evaluation of injectable iron sucrose therapy in children with iron deficiency anemia. Pak Armed Forces Med J 2016; 66(5): 680-83.
4. Khan MS, Khan A, Hussain U, Khan A, Tahir M, Afnan B, Abbas K. Effectiveness and Safety of Intravenous Iron Sucrose Therapy in Children with Iron Deficiency Anemia. Education. 2022;21:13-8.
5. Korczowski B, Farrell C, Falone M, Blackman N, Rodgers T. Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia. Pediatric Research. 2023 Oct;94(4):1547-54.
6. Lepus CA, Samela K, Mokha JS. Efficacy and safety of intravenous iron sucrose in children younger than 2 years with intestinal failure. Nutrition in Clinical Practice. 2023 Aug;38(4):899-903.
7. Namjoshi SS, Muradian S, Bechtold H, et al. Nutrition deficiencies in children with intestinal failure receiving chronic parenteral nutrition. JPEN J Parenter Enteral Nutr. 2018; 42(2): 427-435.
8. Stein RE, Plantz K, Maxwell EC, Mamula P, Baldassano RN. Intravenous iron sucrose for treatment of iron deficiency anemia in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2018; 66(2): e51-e55.
9. Kaneva K, Chow E, Rosenfield CG, Kelly MJ. Intravenous iron sucrose for children with iron deficiency anemia. J Pediatr Hematol Oncol. 2017; 39(5): e259-e262.
10. Nawaz A, Aslam A, Ain Q. Oral versus parenteral iron supplements: which is better in postpartum iron deficiency anemia? Asian J Res Med Pharm Sci 2018; 3(2): 1-6.
11. Zaman S, Shah SA, Jehanzeb K, Sabir S, Rashid HU, Haq ZU. Effect of intravenous iron therapy on serum ferritin and haemogobin levels in children reporting with iron defeciency anaemia. Pak Armed Forces Med J 2020; 70(5): 1344-48.
12. Sillis R. Iron-Deficiency Anemia. In: Kliegman R, Stanton B, St Geme J, Schor N, Eds. Nelson Textbook of Pediatrics, 20th ed. Canada: Elsevier 2016: 2323-6.
13. Kazancı EG, Korkmaz MF, Orhaner B. Efficacy and safety of intravenous iron sucrose treatment in children with iron deficiency anemia. Med Sci Discov 2019; 6(10): 278-83.
14. Nazir F, Khurshid A, Talib MA. Intravenous iron sucrose in malnourished children with iron deficiency anemia. Prof Med J 2020; 27(09): 1867-71.
15. Mantadakis E, Tsouvala E, Xanthopoulou V, Chatzimichael A. Intravenous iron sucrose for children with iron deficiency anemia: a single institution study. World J Pediatr 2016; 12(1): 109-13.
16. Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JM, et al. Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Br J Clin Pharmacol 2018; 84(4): 694-9.
17. Hussain S, Ahmad TM, Sabir MU, Tarar SH. Comparison of efficacy of oral and intramuscular iron supplementation for treatment of iron deficiency anemia in children. Pak Armed Forces Med J 2015; 65(1): 153-9.
18. Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer 2011; 56(4): 615-9.
19. Karadaş N, Töret E, Karadaş U. Is intravenous iron treatment in pediatric patients safe and effective enough?. GUNCEL PEDIATRI. 2022;20(2).
20. Gómez-Ramírez S, Brilli E, Tarantino G, Girelli D, Muñoz M. Sucrosomial® iron: an updated review of its clinical efficacy for the treatment of iron deficiency. Pharmaceuticals. 2023 Jun 6;16(6):847.
21. Auerbach M, Gafter-Gvili A, Macdougall IC. Intravenous iron: a framework for changing the management of iron deficiency. The Lancet Haematology. 2020 Apr 1;7(4):e342-50.
22. Kondrakunta DR. Study of efficacy and compliance of iron sucrose in iron deficiency anaemia in pregnancy. Int J Clin Obstet Gynaecol. 2021;5(5):170-4.